Understanding and treating developmental brain disorders
Following the failure of the phase 3 of autism treatment, our fundamental research had to be stopped. the researchers, engineers and technicians had to leave the company, and the equipment has been sold.
Although the phase III clinical trial was a failure, Neurochlore was able to retrieve data that could be promising. …
IBEN will give a satellite conference at the FENS 2022, an european congress of neurosciences. The conference, which take place …
Our research aims at determining brain development alterations that lead to Autism Spectrum Disorders (ASD) and other Neurodevelopmental Disorders and identifying therapeutic targets.